Terms: = Breast cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Prognosis
42 results:
1. The Diagnostic and Prognostic Value of miR-155 in cancers: An Updated Meta-analysis.
Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
[TBL] [Abstract] [Full Text] [Related]
2. Effects of Infection-Induced Fever and the Interaction with IL6 rs1800796 Polymorphism on the prognosis of breast cancer.
Ye H; Tang LY; Liang ZZ; Chen QX; Li YQ; Liu Q; Xie X; Lin Y; Ren ZF
Cancer Epidemiol Biomarkers Prev; 2022 Nov; 31(11):2030-2037. PubMed ID: 36084325
[TBL] [Abstract] [Full Text] [Related]
3. Neuroendocrine pathways and breast cancer progression: a pooled analysis of somatic mutations and gene expression from two large breast cancer cohorts.
Hu K; Wang C; Luo C; Zheng H; Song H; Bergstedt J; Fall K; Luo T; Czene K; Valdimarsdóttir UA; Fang F; Lu D
BMC Cancer; 2022 Jun; 22(1):680. PubMed ID: 35729536
[TBL] [Abstract] [Full Text] [Related]
4. BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting prognosis in breast cancer.
Wang S; Liu X; Yang M; Yuan D; Ye K; Qu X; Wang X
Dis Markers; 2022; 2022():2760432. PubMed ID: 35493295
[TBL] [Abstract] [Full Text] [Related]
5. Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-breast cancer Drug Targets and Prognostic Markers.
Fang L; Liu Q; Cui H; Zheng Y; Wu C
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456460
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways.
Lan J; Huang J; Tao X; Gao Y; Zhang L; Huang W; Luo J; Liu C; Deng Y; Liu L; Liu X
J Cell Mol Med; 2022 May; 26(9):2673-2685. PubMed ID: 35322916
[TBL] [Abstract] [Full Text] [Related]
7. Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature.
Raffone A; Travaglino A; Raimondo D; Neola D; Maletta M; Santoro A; Insabato L; Casadio P; Fanfani F; Zannoni GF; Zullo F; Seracchioli R; Mollo A
Gynecol Oncol; 2022 Apr; 165(1):192-197. PubMed ID: 35078650
[TBL] [Abstract] [Full Text] [Related]
8. Distant metastasis and prognostic factors in patients with invasive ductal carcinoma of the breast.
Chen X; Zhang C; Guo D; Wang Y; Hu J; Hu J; Wang S; Liu X
Eur J Clin Invest; 2022 Apr; 52(4):e13704. PubMed ID: 34725819
[TBL] [Abstract] [Full Text] [Related]
9. Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer.
Ding S; Sun X; Zhu L; Li Y; Chen W; Shen K
Int Immunopharmacol; 2021 Nov; 100():108122. PubMed ID: 34536743
[TBL] [Abstract] [Full Text] [Related]
10. Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer.
Althobiti M; El-Sharawy KA; Joseph C; Aleskandarany M; Toss MS; Green AR; Rakha EA
Breast Cancer Res Treat; 2021 Oct; 189(3):621-630. PubMed ID: 34453638
[TBL] [Abstract] [Full Text] [Related]
11. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.
Raffone A; Travaglino A; Raimondo D; Neola D; Renzulli F; Santoro A; Insabato L; Casadio P; Zannoni GF; Zullo F; Mollo A; Seracchioli R
Gynecol Oncol; 2021 Aug; 162(2):401-406. PubMed ID: 34088515
[TBL] [Abstract] [Full Text] [Related]
13. [Prognostic values of spindle checkpoint protein bub1b in triple negative breast cancer].
Zhang PC; Zhong XR; Zheng H; Li L; Chen F; Shen MJ; Li YJ; Chen H; Cao SY; Bu H; Ye F
Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):645-649. PubMed ID: 34078054
[No Abstract] [Full Text] [Related]
14. Expression and prognosis analyses of BUB1, bub1b and BUB3 in human sarcoma.
Long Z; Wu T; Tian Q; Carlson LA; Wang W; Wu G
Aging (Albany NY); 2021 Apr; 13(9):12395-12409. PubMed ID: 33872216
[TBL] [Abstract] [Full Text] [Related]
15. Key Genes and Prognostic Analysis in HER2+ breast cancer.
Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y
Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770
[TBL] [Abstract] [Full Text] [Related]
16. Establishment and Validation of Novel Clinical prognosis Nomograms for Luminal A breast cancer Patients with Bone Metastasis.
Tu Q; Hu C; Zhang H; Peng C; Kong M; Song M; Zhao C; Wang Y; Li J; Zhou C; Wang C; Ma X
Biomed Res Int; 2020; 2020():1972064. PubMed ID: 33490234
[TBL] [Abstract] [Full Text] [Related]
17. Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis.
Liu S; Liu X; Wu J; Zhou W; Ni M; Meng Z; Jia S; Zhang J; Guo S; Lu S; Li Y
Medicine (Baltimore); 2020 Dec; 99(49):e23153. PubMed ID: 33285689
[TBL] [Abstract] [Full Text] [Related]
18. Identification of epithelial-mesenchymal transition-related circRNA-miRNA-mRNA ceRNA regulatory network in breast cancer.
Sang M; Wu M; Meng L; Zheng Y; Gu L; Liu F; Sang M
Pathol Res Pract; 2020 Sep; 216(9):153088. PubMed ID: 32825956
[TBL] [Abstract] [Full Text] [Related]
19. Risk of Gynecologic cancer as Second versus First Primary cancer in Japan.
Ogawa C; Nakamura K; Matsuoka H; Matsubara Y; Haraga J; Masuyama H
Acta Med Okayama; 2020 Apr; 74(2):109-114. PubMed ID: 32341584
[TBL] [Abstract] [Full Text] [Related]
20. Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis.
Lin Y; Fu F; Lv J; Wang M; Li Y; Zhang J; Wang C
Medicine (Baltimore); 2020 Jan; 99(1):e18445. PubMed ID: 31895772
[TBL] [Abstract] [Full Text] [Related]
[Next]
